In this study we wished to investigate the potential therapeutic role of PPAR-β/δ activation during an inflammatory process such as, multiple organ dysfunction syndrome (MODS, also known as multiple organ failure (MOF) or multiple organ system failure [10]) caused by zymosan. This evidence concerns the gene PPARD and Multiple Organ Failure.